CLRB Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc. (CLRB) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: May 7, 2026 , by CARUSO JAMES V .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| CARUSO JAMES V | Chief Executive Officer | Buy | 8,680 | $2.88 | $25.0K | 20,318 | |
| Longcor Jarrod | Chief Operating Officer | Buy | 8,680 | $2.88 | $25.0K | 20,451 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.